Go Back
Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers that may be missed by mammography1. Patient-friendly Invenia™ ABUS 2.0 is the first FDA-approved ultrasound supplemental screening technology that is specifically designed for detecting cancer in dense breast tissue.
The LOGIQ E10 Series provides a new standard in imaging to enhance diagnostic confidence for every clinician. Its cSound™ Architecture combines versatile XDclear™ probes, cSound Imageformer and advanced Speckle Reduction Imaging to deliver exceptional image quality.
This powerfully-streamlined solution helps you deliver on the promise of confident care. Technology powerful enough so you can conduct a full spectrum of exams and procedures … and compact enough to let you image patients in almost any space.
